Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Disorders”

547 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 547 results

Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Not applicableStudy completedNCT03838549
What this trial is testing

Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication

Who this might be right for
Genetic PredispositionBreast Cancer
University Hospital, Montpellier 20
Early research (Phase 1)Study completedNCT07466940
What this trial is testing

A Clinical Study to Evaluate SM17 in Healthy Participants

Who this might be right for
Atopic DermatitisAsthmaInflammatory Bowel Disease
SinoMab BioScience Ltd 30
Early research (Phase 1)Study completedNCT07200596
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA)
Guangdong Hengrui Pharmaceutical Co., Ltd 16
Early research (Phase 1)Study completedNCT02738970
What this trial is testing

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 88
Not applicableNot Yet RecruitingNCT07626645
What this trial is testing

Extracorporeal Shock Wave Therapy in Lower Extremity Lymphedema

Who this might be right for
Lymphedema, Lower LimbExtracorporeal Shock Wave TherapyEdema Leg+2 more
Gazi University 36
Not applicableStudy completedNCT01127867
What this trial is testing

A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women

Who this might be right for
Breast CancerObesity
Rockefeller University 17
Early research (Phase 1)Study completedNCT02101073
What this trial is testing

ALX-0061 Phase I Bioavailability Study in Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 70
Not applicableStudy completedNCT02608112
What this trial is testing

Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Early research (Phase 1)Study completedNCT02175056
What this trial is testing

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Who this might be right for
Healthy Volunteers
Handok Inc. 58
Testing effectiveness (Phase 2)Study completedNCT04137224
What this trial is testing

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring 27
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Not applicableUnknownNCT04499001
What this trial is testing

Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs

Who this might be right for
Arthritis, RheumatoidSpondyloarthritisBiological Therapy
Hôpital Cochin 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04909801
What this trial is testing

Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 338
Testing effectiveness (Phase 2)Study completedNCT01987609
What this trial is testing

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Who this might be right for
Psoriasis
Tissa Hata, MD 7
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Large-scale testing (Phase 3)Study completedNCT00097695
What this trial is testing

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Who this might be right for
Angioedema
Shire 84
Early research (Phase 1)Study completedNCT06929039
What this trial is testing

Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA
Kashiv BioSciences, LLC 300
Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Load More Results